Shanghai Kehua Bio-engineering Co Ltd - Company Profile

Powered by

All the data and insights you need on Shanghai Kehua Bio-engineering Co Ltd in one report.

  • Save hours of research time and resources with
    our up-to-date Shanghai Kehua Bio-engineering Co Ltd Strategy Report

  • Understand Shanghai Kehua Bio-engineering Co Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Shanghai Kehua Bio-engineering Co Ltd: Overview

Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s product portfolio includes COVID-19 products, immunologic diagnosis, biochemical diagnosis, molecular diagnosis and POCT (point-of-care testing) products. It also offers comprehensive services for regional medical communities. KHB established R&D centers and production bases in many countries and regions including Italy. The company has sales support facilities in major cities in China and markets products in China and other countries through distributors. It is also a global supplier of IVD products to WHO, UNICEF, PEPFAR, and Clinton HIV/AIDS Initiative. KHB is headquartered in Shanghai, China.

Gain a 360-degree view of Shanghai Kehua Bio-engineering Co Ltd and make more informed decisions for your business Gain a 360-degree view of Shanghai Kehua Bio-engineering Co Ltd and make more informed decisions for your business Find out more
Headquarters China

Address No.1189, Qinzhou North Road, Xuhui District, Shanghai, 200233


Telephone 86 21 64954576

No of Employees 2,709

Industry Medical Equipment

Ticker Symbol & Exchange 002022 (SHE)

Revenue (2022) $1.0B 43.6% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ 14.2% (2022 vs 2021)

Market Cap* $487.5M

Net Profit Margin (2022) XYZ -20.5% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Shanghai Kehua Bio-engineering Co Ltd premium industry data and analytics

1

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

Products and Services

Products Brands
- KHB
Diagnostic Kit for SARS-CoV-2 IgM/IgG Antibody (Colloidal Gold)
Diagnostic Kit for SARS-CoV-2 Nucleic Acid (Real Time PCR)
XYZ
XYZ
XYZ
Understand Shanghai Kehua Bio-engineering Co Ltd portfolio and identify potential areas for collaboration Understand Shanghai Kehua Bio-engineering Co Ltd portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In January, the company entered into an agreement with Xinshao County People's Hospital jointly to build a cooperative demonstration unit and introduce the KHB Polaris LAS automatic biochemical immune assembly line.
2023 Contracts/Agreements In December, Kehua Biotech and the Department of Infectious Diseases of Jiangxi Provincial People's Hospital joined forces to launch free-of-charge treatment for a standardized diagnosis and to cure hepatitis patients.
2022 Contracts/Agreements In November, Kehua Biologics and Shanghai MCC Hospital entered into a clinical translation research center cooperation agreement to improve scientific research capabilities to strengthen the construction of innovative talent teams.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Shanghai Kehua Bio-engineering Co Ltd Shenzhen Mindray Bio-Medical Electronics Co Ltd Daan Gene Co Ltd Edan Instruments Inc Beijing Strong Biotechnologies Inc
Headquarters China China China China China
City Shanghai Shenzhen Guangzhou Shenzhen Beijing
State/Province Shanghai Guangdong Guangdong Guangdong Beijing
No. of Employees 2,709 16,099 3,580 2,711 1,094
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Ma Zhichao Chairman Executive Board - 43
Fang Luo Chief Financial Officer Senior Management - 51
Chao Chen Senior Vice President; Director Executive Board - 46
Li Ming President Senior Management 2023 47
Wang Xilin Vice President Senior Management - 53
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Shanghai Kehua Bio-engineering Co Ltd key executives to enhance your sales strategy Gain insight into Shanghai Kehua Bio-engineering Co Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward